Switch View
© Globe Newswire
06.11.2025
ISIN: US2546041011
Disc Medicine Inc
IRON
LISTED
NASDAQ
Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
WATERTOWN, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today reported financial results for the third quarter ended September 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: CA82621K1021
Sienna Senior Living Inc
SIA
LISTED
TSX
Sienna Expands Retirement Portfolio in Key Ontario Market
News Preview
MARKHAM, Ontario, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced today that it has entered into a purchase agreement to acquire The Hygate on Lexington (“Hygate”), a 216-suite retirement residence in Waterloo, Ontario....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US45175G2075
ImageneBio, Inc
IMA
LISTED
NASDAQ
ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
News Preview
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” “Company”), a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases, including IMG-007, an anti-OX40 monoclonal antibody with multiple differentiating features, today announced managem...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
06.11.2025
ISIN: US68622V1061
Organon & Co
OGN
LISTED
NYSE
Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025
News Preview
Organon (NYSE: OGN), a global healthcare company with a primary focus on women’s health, will release its third quarter 2025 financial results on November 10, 2025, prior to the company’s webcast and conference call scheduled for 8:30 a.m. ET.
The webcast and conference call will be hosted by Carrie Cox, Organon’s Executive Board Chair; Joe Morri...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
06.11.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene Announces First Participant Dosed in Embolden™ Registrational Trial of NGN-401 Gene Therapy for Rett Syndrome
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the first participant was dosed in the Embolden™ registrational clinical trial of NGN-401, a gene therapy in development for the treatment of Rett syndrome. N...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US64049M2098
Neogenomics Inc
NEO
LISTED
NASDAQ
NeoGenomics to Participate in Upcoming Investor Conferences
News Preview
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the following investor conferences:
Stephens Annual Investment Conference in Nashville, TN
Company presentation on Wednesday, November 19, at 1:00 pm CT, accessible here
Piper Sandl...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US8006771062
Sangamo Therapeutics Inc
SGMO
LISTED
NASDAQ
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results
News Preview
SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND THIRD QUARTER 2025 FINANCIAL RESULTS...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: CA94947L1022
WELL Health Technologies Corp
WELL
LISTED
TSX
WELL Health Reports Record Revenue, Record Adjusted EBITDA, and Record Adjusted Net Income in Q3-2025 Driven by Strong Performance in Core Canadian Businesses
News Preview
WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its interim consolidated financial results for the quarter ended September...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: IL0011407140
Urogen Pharma Ltd
URGN
LISTED
NASDAQ
UroGen Reports Third Quarter 2025 Financial Results as ZUSDURI™ Launch Gains Momentum
News Preview
PRINCETON, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced financial results for the third quarter ended September 30, 2025, and provided an overview of recent developments....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update
News Preview
WOBURN, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal second quarter ended September 30, 2025 and provided a business update....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US55287L1017
MBX Biosciences, Inc.
MBX
LISTED
NASDAQ
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
News Preview
Reported positive topline results from the Phase 2 Avail™ trial of once-weekly canvuparatide in hypoparathyroidism (HP)...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US24906P1093
DENTSPLY SIRONA Inc
XRAY
LISTED
NASDAQ
Dentsply Sirona Reports Third Quarter 2025 Results
News Preview
CHARLOTTE, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2025 and introduced its Return-to-Growth action plan, a comprehensive strategy to improve performance and position the Company for sustained, profitable growth o...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
06.11.2025
ISIN: US98887Q1040
Zai Lab Limited
ZLAB
LISTED
NASDAQ
Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the third quarter of 2025, along with recent product highlights and corporate updates.
“Zai Lab is entering the next phase of our growth, powered by the rapid advancement of our global pipeline and supported by a commercially profitable and scalable business in China...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: CA24874B1085
dentalcorp Holdings Ltd.
DNTL
LISTED
TSX
Dentalcorp Reports Third Quarter 2025 Results
News Preview
dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL), Canada’s largest and one of North America’s fastest growing networks of dental practices, today announced its financial and operating results for the third quarter ended September 30, 2025. All financial figures are in Canadian dollars unless otherwise indicated.
“We delivered...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US03237H1014
Amylyx Pharmaceuticals Inc
AMLX
LISTED
NASDAQ
Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
News Preview
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today reported financial and business results for the third quarter ended September 30, 2025.
“Entering the final months of 2025, we are focused on execution as we head toward a transformative year in 2026, with topline data expected from the pivotal Phase 3 LUCIDITY trial,”...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US98422E1038
Xeris Biopharma Holdings Inc
XERS
LISTED
NASDAQ
Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025
News Preview
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced financial results for the third quarter ended September 30, 2025.
“We delivered another record-breaking quarter, driven by i...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US01438T1060
Aldeyra Therapeutics Inc
ALDX
LISTED
NASDAQ
Aldeyra Therapeutics to Host Research & Development Update Webcast Event Scheduled for Thursday, November 13 at 8:00 a.m. ET
News Preview
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company developing innovative therapies for the treatment of immune-mediated diseases, today announced that the company will host a Research & Development Update webcast on Thursday, November 13, 2025 at 8:00 a.m. ET.
Aldeyra will provide a review of pipeline...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: GB0009895292
AstraZeneca PLC
AZN
LISTED
LSE
AstraZeneca's 9M and Q3 2025 Financial Results
News Preview
AstraZeneca:
Revenue and EPS summary
9M 2025
% Change
Q3 2025
% Change
$m
Actual
CER1
$m
Actual
CER
- Product Sales
41,035
9
9
14,365
11
9
- Alliance Revenue
2,108
41
41
815
46
44
Product Revenue2
43,143
10...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US92556V1061
Viatris Inc
VTRS
LISTED
NASDAQ
Viatris Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance
News Preview
Delivers Total Revenues in Line With Expectations, Reflecting Strong Execution of its Global Business
Makes Late-Stage Pipeline Progress Including NDA Submission for Low-Dose Estrogen Weekly Patch...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight
News Preview
Based on these trial results, Lilly will begin enrolling Phase 3 clinical studies for the treatment of obesity next month
INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive results from a Phase 2 trial evaluatin...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
News Preview
Q4 revenue of $5.9 billion increased 8.3% as reported, 7.0% FXN and 3.9% organic
Q4 GAAP and adjusted diluted EPS grew to $1.72 and $3.96, respectively
FY25 revenue of $21.8 billion increased 8.2% as reported, 7.7% adjusted FXN and 2.9% organic
FY25 GAAP EPS o...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: CA22717L1013
Cronos Group. Inc.
CRON
LISTED
TSX
Cronos Group Reports 2025 Third Quarter Results
News Preview
Achieved record levels of consolidated net revenue, gross profit and Adjusted EBITDA...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: KYG2545C1042
Crescent Biopharma, Inc.
CBIO
LISTED
NASDAQ
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
News Preview
IND Submission for CR-001, a PD-1 x VEGF Bispecific Antibody, on Track for Fourth Quarter of 2025 to Support Initiation of Global Phase 1 Trial in Patients with Solid Tumors ...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US00887A2042
Rein Therapeutics Inc
ALRN
LISTED
NASDAQ
Rein Therapeutics Announces New Scientific Publication Demonstrating LTI-03 May Reduce Lung Scarring and Protect Cells Needed for Lung Repair in IPF
News Preview
New data builds on prior results, highlights LTI-03's differentiated approach, and supports the ongoing global Phase 2 RENEW trial New data builds on prior results, highlights LTI-03's differentiated approach, and supports the ongoing global Phase 2 RENEW trial...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: CA4990531069
Knight Therapeutics Inc
GUD
LISTED
TSX
Knight Therapeutics Reports Third Quarter 2025 Results
News Preview
Achieved record-high quarterly revenues, Adjusted EBITDA1 and Adjusted EBITDA per share1 since inception Increased 2025 financial guidance...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US5288723027
Lexicon Pharmaceuticals Inc
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides R&D Updates
News Preview
Lexicon Pharmaceuticals reported third quarter 2025 financial results and provided an update on key corporate milestones and accomplishments....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US6979471090
Palvella Therapeutics Inc
PVLA
LISTED
NASDAQ
Palvella Therapeutics to Present at the Stifel 2025 Healthcare Conference
News Preview
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases for which there are no U.S. Food and Drug Administration (FDA)-appro...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US19459J1043
Collegium Pharmaceutical Inc
COLL
LISTED
NASDAQ
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
News Preview
– Generated Record Quarterly Net Revenue of $209.4 Million, Up 31% Year-over-Year –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US09203E1055
Black Diamond Therapeutics Inc
BDTX
LISTED
NASDAQ
Black Diamond Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today reported financial results for the third quarter ended September 30, 2025, and provided a corporate update....
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US45784P1012
Insulet Corp
PODD
LISTED
NASDAQ
Insulet Reports Third Quarter 2025 Results
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the three months ended September 30, 2025.
Third Quarter Financial Highlights:
Revenue of $706.3 million, increased 29.9%, or 28.2% in constant currency...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Board Increases Dividend for 54th Consecutive Year
News Preview
FRANKLIN LAKES, N.J., Nov. 6, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.05 per common share, an increase of 1.0% from the previous quarter. The dividend will be payable on December 31, 2025 to holders of record on December...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Yunqi Capital Applauds STAAR Surgical’s Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated
News Preview
Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today released the following letter to the Board of Directors of STAAR after reviewing STAAR’s third quarter earnings press release an...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
uniQure to Announce Third Quarter 2025 Financial Results
News Preview
~ uniQure to host earnings call on Monday, November 10, 2025 at 8:30 a.m. ET ~ ~ uniQure to host earnings call on Monday, November 10, 2025 at 8:30 a.m. ET ~...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: CA01559R1038
Algernon Pharmaceuticals Inc.
AGN
LISTED
CSE
Algernon Health Announces Private Placement
News Preview
VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce a non-brokered private placement for gross proceeds of $500,000 (the “Offering”) of units (the “Units”) at an issue price of $0.07 per...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
BEDFORD, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US28658R1068
Climb Bio, Inc
CLYM
LISTED
NASDAQ
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
News Preview
PrisMN Phase 2 trial of budoprutug in Primary Membranous Nephropathy (pMN) initiated ...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US00534A1025
Invivyd Inc
IVVD
LISTED
NASDAQ
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
News Preview
NEW HAVEN, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the quarter ended September 30, 2025, and provided recent business highlights....
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US4050241003
Haemonetics Corp
HAE
LISTED
NYSE
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
News Preview
Financial release and supplemental presentation accessible online
BOSTON, Nov. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2026, which end...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US03837C1062
Apyx Medical Corp
APYX
LISTED
NASDAQ
Apyx Medical Corporation Reports Third Quarter 2025 Financial Results
News Preview
CLEARWATER, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US75383L1026
Rapport Therapeutics Inc.
RAPP
LISTED
NASDAQ
Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update
News Preview
BOSTON and SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today reported financial results for the th...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US53220K5048
Ligand Pharmaceuticals Inc
LGND
LISTED
NASDAQ
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
News Preview
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US6409791000
Neumora Therapeutics Inc
NMRA
LISTED
NASDAQ
Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Announced class-leading data from diet-induced obesity (DIO) mouse model with NMRA-215, a potentially best-in-class, highly brain-penetrant, oral NLRP3 inhibitor, and expect to initiate Phase 1 study in first quarter of 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US05464T1043
Axsome Therapeutics Inc
AXSM
LISTED
NASDAQ
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy
News Preview
Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA α2,3 receptor positive allosteric modulator...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US0044685008
Achieve Life Sciences, Inc.
ACHV
LISTED
NASDAQ
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
News Preview
One of Only Nine Therapies Chosen for the Inaugural FDA Commissioner’s National Priority Voucher for E-cigarette or Vaping CessationConference Call Scheduled for 8:30 AM EST Today, November 6, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: NL0010872495
ProQR Therapeutics NV
PRQR
LISTED
NASDAQ
ProQR Announces Third Quarter 2025 Operating and Financial Results
News Preview
LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today reported its financial and operating results for the third quarter ended...
Themefolio
Profiler
Peergroup
© Newsfile
06.11.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness QSR Secures First U.S. Real-Estate Location in Lubbock, Texas
News Preview
Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands, is pleased to announce that Heal Wellness ("Heal") has secured its first U.S. real-estate location in the State of Texas-an important step towards ou...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US07725L1026
BeOne Medicines Ltd.
ONC
LISTED
NASDAQ
BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates
News Preview
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the third quarter of 2025.
“These strong financial results reinforce our position as a global oncology leader with exceptional topline growth and a strong balance sheet,” said John V. Oyler, Co-Foun...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US8793691069
Teleflex Inc
TFX
LISTED
NYSE
Teleflex Announces Quarterly Dividend
News Preview
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2025, to shareholders of record at the close of business on November 14, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: INE061F01013
Fortis Healthcare Ltd
FORTIS
LISTED
BSE
Decade-Long Study by Fortis Memorial Research Institute (FMRI) Gurugram Reveals Breakthrough in Treating Children with Sickle Cell Disease via Stem Cell Transplant
News Preview
In a landmark advancement for Indian healthcare, doctors at FMRI, Gurugram, have reported exceptional success in curing children suffering from Sickle Cell Disease (SCD) through Bone Marrow (stem cell) transplantation, a development that places India among the leading nations in advanced paediatric transplant outcomes.
The decade-long study, publ...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: CA10919W4056
Bright Minds Biosciences Inc.
DRUG
LISTED
NASDAQ
Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH
News Preview
-- Company will host a webcast at 10am ET on November 6, 2025, to discuss its Phase 2a study to assess efficacy, safety and tolerability of BMB-101 (NOVA Study) for the treatment of patients with Prader-Willi Syndrome -- -- Key Opinion Leaders (KOLs) participating on the call will include Theresa V. Strong, PhD., Jennifer L. Miller, MD, and Elizabe...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US8793691069
Teleflex Inc
TFX
LISTED
NYSE
Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
News Preview
WAYNE, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 28, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US05356F1057
Aveanna Healthcare Holdings Inc
AVAH
LISTED
NASDAQ
Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook
News Preview
ATLANTA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods ended September 27, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US35104E1001
4D Molecular Therapeutics Inc
FDMT
LISTED
NASDAQ
4DMT Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
News Preview
EMERYVILLE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced the pricing of an underw...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: CNE1000040M1
Hangzhou Tigermed Consulting Co., Ltd
3347
LISTED
HKSE
Tigermed Selected as "2025 Forbes China Go-International Flagship Brands" Top 30
News Preview
HANGZHOU, China, Nov. 6, 2025 /PRNewswire/ -- Tigermed has been selected as one of the Top 30 companies on the "2025 Forbes China Go-International Flagship Brands" list, Forbes China announced Tuesday.
Forbes China launched the Go-International...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: CNE1000040M1
Hangzhou Tigermed Consulting Co., Ltd
3347
LISTED
HKSE
Tigermed Selected as "2025 Forbes China Go-International Flagship Brands" Top 30
News Preview
HANGZHOU, China, Nov. 6, 2025 /PRNewswire/ -- Tigermed has been selected as one of the Top 30 companies on the "2025 Forbes China Go-International Flagship Brands" list, Forbes China announced Tuesday....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US1940145022
Enovis Corp
ENOV
LISTED
NYSE
Enovis Announces Third Quarter 2025 Results
News Preview
Dallas, TX, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter ended October 3, 2025. The Company will host an investor conference call and live webcast to discuss these results today at...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US74276R1023
Privia Health Group Inc
PRVA
LISTED
NASDAQ
Privia Health Reports Third Quarter 2025 Financial Results
News Preview
Privia Health Reports Very Strong Q3 and YTD Results Across the Business; FY’25 Guidance Raised Above High End for All Key Operating and Financial Metrics...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US74112D1019
Prestige Consumer Healthcare Inc
PBH
LISTED
NYSE
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results
News Preview
TARRYTOWN, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US53228F1012
LifeStance Health Group Inc
LFST
LISTED
NASDAQ
LifeStance Reports Third Quarter 2025 Results
News Preview
SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US35104E1001
4D Molecular Therapeutics Inc
FDMT
LISTED
NASDAQ
4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD Supporting 4D-150’s Potential as a Backbone Therapy with Consistent and Durable Benefit over Multiple Years
News Preview
EMERYVILLE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced positive interim 1.5- to...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
